Annovis Bio Inc. (ANVS) Fundamentals

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.
SHARE INFORMATION
Market Cap$ 111,845,745
Shares Outstanding8,163,923
Float5,638,000
Percent Float69.06%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.90
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions73
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months64,788
Institutional Holdings Percent18.7%
Institutional Sold Previous 3 Months119,645
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months120,000
Insider Holdings Percent32.1
Insider Sold Previous 3 Months-
Insider Shares Owned2,621,623
TRADING INFO
52 Week High$ 39.72
52 Week Low$ 8.39
52 Week High Change$ -56.85
21 Day Moving Average$ 15.0957
21 Day Extended Moving Average$ 14.4916
50 Day Moving Average$ 13.078
50 Day Extended Moving Average$ 13.6514
200 Day Moving Average$ 13.2416
200 Day Extended Moving Average$ 15.9459
10 Day Average Volume117,414
20 Day Average Volume165,599
30 Day Average Volume121,963
50 Day Average Volume86,562
Alpha0.072437
Beta1.6196
Standard Deviation0.430642
R20.051109
7 Day Price Change$ 0.36
7 Day Percent Change2.7%
21 Day Price Change$ -1.60
21 Day Percent Change-10.46%
30 Day Price Change$ 2.10
30 Day Percent Change18.1%
Month to Date Price Change$ 2.10
Month to Date Percent Change18.1%
Quarter to Date Price Change$ 2.36
Quarter to Date Percent Change20.81%
180 Day Price Change$ 0.35
180 Day Percent Change2.62%
200 Day Price Change$ 1.30
200 Day Percent Change10.48%
Year to Date Price Change$ -3.88
Year to Date Percent Change-22.07%

Annovis Bio Inc. (ANVS) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book3.20
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio28.10
Leverage Ratio1.00
Quick Ratio27.70
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-4.70
Enterprise Value$ 75,871,494
Price to Sales0.00
Price to Free Cash-9.70
PE High Last 5 Years0.00
Price To Book3.20
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book3.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-58.25
Return on Equity-59.80
Return on Capital-55.92

Annovis Bio Inc. (ANVS) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorWithumSmith+Brown, PC
CEOMaria Maccecchini
Emplyoees3
Last AuditUQ
CIK0001477845
IndustryBiotechnology
SectorHealthcare
NAICSMedicinal and Botanical Manufacturing(325411)
CONTACT INFO
Address1055 Westlakes Drive
Suite 300
Berwyn, PA 19312
Websitehttps://www.annovisbio.com
Facsimile+1 610 727-4001
Telephone+1 610 727-3913
Email-
Your Recent History
NYSE
ANVS
Annovis Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20221003 03:04:40